Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Comment by narmacon Feb 03, 2022 7:59am
240 Views
Post# 34392278

RE:RE:Sweeney & McCaffrey yesterday on CBC Radio!

RE:RE:Sweeney & McCaffrey yesterday on CBC Radio!Hi,,,GV,,,I have never lost interest in the science,,,,which most other investors hold onto as well. I am sick and tired off the ineptness within the management team around accompilishing anything substantial,,,,,,heading into the third year of nothingness is enuff to make old people start inventing new curse words!!!!!,,,,,I still am on the fence as to what this team of misfits will be able to do with even good data ,,and thats if we do get it,,,I am worried the patients C19 status is incorrect for treatment! Eversana maybe the driving force behind the new and greatly improved information sessions. DMcC couldnt even allow Sweeney to speak alone on behalf of the company in the CBC blurb. Albeit DMcC did add depth to the interview,,that undoubtedly was an accident. Pinocchio will never shake off his false statements these past years, He just cant be believed in any fashion. I would like to hear Eversana speak in tandem with Dr. Kulikowski,,she is a looker and would definitely increase awareness in all aspects of this forward push of the science!!!!!
<< Previous
Bullboard Posts
Next >>